中国P站

Breastfeeding; Infant immunity; Passive immunity; Human milk oligosaccharides; Secretory IgA; Microbiome; Immunological development; Neonatal health; Maternal antibodies; Immune programming

Introduction

Breastfeeding is universally acknowledged as the optimal source of nutrition for infants, but its benefits extend far beyond basic nourishment. Human breast milk is a dynamic and bioactive substance uniquely tailored to meet the physiological and immunological needs of infants [1]. The early months of life are a vulnerable period during which infants rely heavily on maternal antibodies and immune factors to defend against environmental pathogens. Since the infant’s own immune system is still immature at birth, breastfeeding serves as a critical bridge that offers passive immunity and supports the development of the infant’s adaptive immune functions [2]. The World Health Organization (WHO) and UNICEF recommend exclusive breastfeeding for the first six months of life, followed by continued breastfeeding along with complementary foods up to two years or beyond [3]. This recommendation is grounded in the strong evidence base supporting breastfeeding as a modulator of early-life immunity, capable of reducing the incidence and severity of infectious diseases, allergies, and autoimmune conditions [4]. Breastfeeding is universally recognized as the gold standard of infant feeding, not only for its unparalleled nutritional value but also for its profound immunological benefits. From the moment of birth, an infant’s immune system is immature and vulnerable to a wide range of pathogens and environmental stressors. In this critical window of immune development, human breast milk acts as a natural immunological bridge, transferring passive immunity from the mother while simultaneously aiding in the maturation of the infant's own immune system [5]. Human milk is a biologically active fluid composed of a diverse array of immunoprotective factors. Secretory Immunoglobulin A (sIgA), the predominant antibody in breast milk, provides mucosal protection in the infant’s gut, respiratory tract, and other mucosal surfaces. Other components such as lactoferrin, lysozyme, human milk oligosaccharides (HMOs), and maternal leukocytes contribute to antimicrobial defense, immune modulation, and the nurturing of a beneficial microbiome [6]. These elements not only defend the infant against common infections such as diarrhea and pneumonia but also shape immune regulation and tolerance, reducing the risk of allergic and autoimmune diseases later in life. In addition, breastfeeding fosters the establishment of a healthy gut microbiome, which is essential for immune system calibration [7]. The interplay between HMOs in breast milk and specific bacterial species like Bifid bacterium leads to a gut environment that supports immune balance and inflammation control. Evidence also suggests that exclusive and prolonged breastfeeding is associated with a decreased risk of chronic conditions such as obesity, type 1 and type 2 diabetes, and cardiovascular diseases in adulthood. Despite its numerous benefits, breastfeeding rates remain suboptimal in many parts of the world due to social, cultural, economic, and healthcare system barriers. This underscores the need for sustained advocacy, supportive public health policies, and education to protect and promote breastfeeding as a vital investment in the health of future generations [8].

This article delves into the immunological components of breast milk, the pathways through which they support infant immunity, and their long-term effects on child health.

Breast milk composition and immunological components

Human milk contains numerous bioactive molecules that play a pivotal role in immune protection:

sIgA is the most abundant immunoglobulin in human milk. It binds to pathogens in the infant’s gut, neutralizing them and preventing their attachment to mucosal surfaces without eliciting inflammatory responses.

This iron-binding glycoprotein exhibits bacteriostatic and bactericidal properties by depriving bacteria of iron necessary for growth and disrupting microbial membranes. HMOs are prebiotic compounds that foster the growth of beneficial gut bacteria such as bifid bacteria, thereby contributing to a healthy gut microbiota and enhancing mucosal immunity. They also act as decoy receptors that prevent pathogens from binding to intestinal epithelial cells. Breast milk contains cytokines (e.g., interleukins, tumor necrosis factor) and growth factors (e.g., epidermal growth factor, transforming growth factor-beta) that modulate immune responses and aid in tissue development.

Immune cells in milk, such as macrophages, neutrophils, and lymphocytes, provide cellular defense and may transfer immunological memory. Emerging evidence also suggests the presence of stem cells that may contribute to tissue regeneration in infants.

Reduced incidence and severity of pneumonia, bronchiolitis, and otitis media. Lower rates of diarrhoea and enteric infections due to antimicrobial factors and improved gut barrier function. Protective effects possibly linked to enhanced mucosal immunity. Particularly important in preterm and low-birth-weight infants.

Conclusion

Breastfeeding is more than a mode of nutrition it is a vital immunological process that provides passive protection, facilitates immune development, and influences lifelong health trajectories. Understanding and promoting breastfeeding as a public health priority is essential for reducing infant morbidity and mortality, especially in resource-limited settings. Continued research into the immunological complexity of breast milk and its implications will pave the way for innovative approaches in infant health and nutrition.